Cover Image
Market Research Report

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2017

Published by GlobalData Product code 240613
Published Content info 68 Pages
Delivery time: 1-2 business days
Price
Back to Top
Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2017
Published: August 11, 2017 Content info: 68 Pages
Description

GlobalData's clinical trial report, "Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2017" provides an overview of Eosinophilic Esophagitis clinical trials scenario. This report provides top line data relating to the clinical trials on Eosinophilic Esophagitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC4442CTIDB

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Clinical Trials by G7 Countries: Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by Phase 16
  • In Progress Trials by Phase 17
  • Clinical Trials by Trial Status 18
  • Clinical Trials by End Point Status 19
  • Subjects Recruited Over a Period of Time 20
  • Clinical Trials by Sponsor Type 21
  • Prominent Sponsors 22
  • Top Companies Participating in Eosinophilic Esophagitis Therapeutics Clinical Trials 24
  • Prominent Drugs 25
  • Clinical Trial Profile Snapshots 26

Appendix 66

  • Abbreviations 66
  • Definitions 66
  • Research Methodology 67
  • Secondary Research 67
  • About GlobalData 68
  • Contact Us 68
  • Source 68

List of Tables

List of Tables

  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 13
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Phase, 2017* 16
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 17
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
  • Eosinophilic Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 21
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25

List of Figures

List of Figures

  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 13
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 16
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 17
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
  • Eosinophilic Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 21
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 22
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25
  • GlobalData Methodology 67
Back to Top